# Cellaïon: Research, Mont-Saint-Guibert, Belgium

> Cellaïon: Cellaïon is a Belgian biotechnology company based in Mont-Saint-Guibert, Wallonia. Based in Mont-Saint-Guibert, Belgium. Founded 2021.

Source: https://millionrounds.com/startup/cella-on (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Research startup](https://millionrounds.com/companies)

# Cellaïon

Cellaïon is a Belgian biotechnology company based in Mont-Saint-Guibert, Wallonia.

Funding reported Last round: Series D

Research Mont-Saint-Guibert, Belgium

Company summary

- **Founded:** 2021 5 years old
- **Team:** 10 1 to 10 people
- **Funding reported:** 135.5M as listed, currency not stated
- **Last round:** Series D Dec 2019

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Cellaïon has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Cellaïon

Cellaïon is a Belgian biotechnology company based in Mont-Saint-Guibert, Wallonia.

Founded in March 2021, the company focuses on developing advanced cell-based therapies aimed at repairing tissues and regenerating organs, particularly for life-threatening liver diseases. Cellaïon’s mission is to prolong life through innovative cell signaling technology. The company’s flagship product, HepaStem®, is an allogeneic advanced therapy derived from liver stem cells. It utilizes cell signaling technology to provide immunomodulatory and antifibrotic effects, helping to halt disease progression and promote liver recovery. HepaStem® is currently in Phase IIb clinical development, targeting conditions such as Acute-on-Chronic Liver Failure (ACLF), acute alcoholic hepatitis, and progressive non-alcoholic steatohepatitis (NASH). Cellaïon collaborates with pharmaceutical partners to develop treatments based on its proprietary Signaling Cell Platform. The company has successfully raised significant funding to support its mission, positioning itself as a key player in the field of regenerative medicine for liver diseases.

## What company datasets say Cellaïon raised

Funding, as reported

Reported in all **135.5M** in the source's currency

Last round **Series D**

Last round size **8.3M**

Last round date **Dec 2019**

## On 2 portfolio pages

Investors who name them

- [Fund+](https://millionrounds.com/fund/fundplus)
- [Newton Biocapital](https://millionrounds.com/fund/newton-biocapital)

Each firm lists Cellaïon on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

chronic liver disease biotechnology research fatty liver cell therapy antibodies clinical stage biotechnology biotech liver based genetic diseases liver diseases nash regenerative medicine aclf acute liver disease acquired liver diseases

Built with from their website

Google Tag Manager WordPress.org Exclaimer Elementor Viewport Meta AddThis CookieYes Google Analytics Cloudflare Rocket Loader Vimeo

+8 more

Google Analytics 4 Wordpress Microsoft Exchange Online Google Font API Microsoft Exchange Nginx Microsoft 365 MySQL

- **Sector:** Research
- **Industry code:** NAICS 541714, 325414, SIC 8731, 2836
- **Region:** Walloon Region
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/cellaion)

## Research in Belgium

Startups like it

- [**Fyteko** Anderlecht · founded 2014 *Raised*](https://millionrounds.com/company/fyteko)
- [**Precirix** Jette · founded 2014](https://millionrounds.com/startup/precirix)
- [**Full-Life Technologies** Gembloux · founded 2021](https://millionrounds.com/startup/full-life-technologies)
- [**Augustine Therapeutics** Leuven · founded 2019](https://millionrounds.com/startup/augustine-therapeutics)
- [**NOVADIP Biosciences S.A.** Mont-Saint-Guibert · founded 2013](https://millionrounds.com/startup/novadip-biosciences-s-a)
- [**EyeD Pharma** Seraing · founded 2012](https://millionrounds.com/startup/eyed-pharma)
- [**atbtherapeutics** Marche-en-Famenne · founded 2018](https://millionrounds.com/startup/atbtherapeutics)
- [**Imcyse SA** Liege · founded 2011](https://millionrounds.com/startup/imcyse-sa)

## Is this your company?

Add your raise, your deck and your story, and put Cellaïon in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)